Market Overview:
The global digital PCR (dPCR) and real-time PCR (qPCR) market is expected to register a CAGR of 10.8% during the forecast period, 2018–2030. The dPCR segment is expected to witness a higher growth rate as compared to the qPCR segment, owing to its advantages such as high accuracy and sensitivity. In terms of application, the clinical segment is projected to account for the largest share of the global digital PCR (dPCR) and real-time PCR (qPCR) market in 2018. This can be attributed to increasing demand for molecular diagnostics in clinics across the globe. North America accounted for majority of the share in 2017 and is projected to maintain its dominance during the forecast period.
Product Definition:
Digital PCR (dPCR) is a technique used to amplify and detect nucleic acids in a digital format. This allows for the detection of very low numbers of target sequences in a sample. dPCR can be used for quantitation, genotyping, and copy number determination. Real-time PCR (qPCR) is a type of polymerase chain reaction that monitors the progress of amplification in real time by measuring the amount of fluorescence generated during DNA synthesis. qPCR can be used for gene expression profiling, detection and quantification of pathogens, and genetic variation studies.
dPCR:
dPCR and qPCR are two different names for the same technique. The difference between both these techniques is that dPCR uses a digital detection method, while qPCR uses a quartz-based timing system to measure the PCR cycles. Both these technologies provide highly accurate results in relatively less time as compared to other conventional PCR techniques.
qPCR:
qPCR is an abbreviation for quantitative PCR. It is a method used to measure the amount of DNA in a sample by using the principle of reverse transcription polymerase chain reaction. The qPCR market has been analyzed with respect to two segments, which are dPCR and qPCR. The former one refers to multiplex PCR while latter one refers to singleplex PCR or real-time PCR (RT-PCR).
Application Insights:
The research application segment dominated the global market in 2017. This is attributed to the rising adoption of dPCR and qPCR for research purposes across various applications such as clinical diagnosis, molecular epidemiology, toxicology screening and food safety testing. Moreover, increasing R&D investments by companies for the development of new products are also expected to boost growth during the forecast period.
The other segment includes applications such as environmental testing (e.g., water and soil contamination), food safety/quality testing (e.g., detection of pesticides or heavy metals) and forensics (e.g., identification of DNA).
Regional Analysis:
North America dominated the global market in terms of revenue in 2017. This can be attributed to the presence of a large number of research institutes and clinical laboratories that use PCR instruments for various applications. The U.S., which is at the forefront, has more than 12,000 registered clinical diagnostic laboratories that use PCR devices for testing purposes.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising investments by governments and private entities in healthcare infrastructure development coupled with increasing demand for advanced technologies such as digital PCR and real-time qPCR from both research institutes and clinics across emerging economies including China, India, Singapore & Malaysia (CISM) region; Indonesia; Thailand & Philippines). These factors are anticipated to contribute toward regional growth during the forecast period. Moreover, an increase in disease prevalence levels due to changing lifestyles along with exposure towards infectious diseases will also boost demand within Asia Pacific region over this forecast period (2018 - 2030).
Growth Factors:
- Increasing demand for early diagnosis and treatment of diseases: The ability to detect minute quantities of target DNA sequences in a sample has made dPCR and qPCR ideal techniques for the detection of rare genetic variants, mutations, and pathogens. This is driving the adoption of these technologies in clinical diagnostics laboratories.
- Rising prevalence of cancer: According to the World Health Organization (WHO), cancer is one of the leading causes of death worldwide, accounting for 8.8 million deaths in 2012. The increasing incidence rate of various types cancers is fueling demand for dPCR and qPCR-based diagnostic tests that can help identify tumor markers at an early stage for better prognosis and treatment options.
- Growing application areas: In addition to its use in clinical diagnostics, dPCR has found applications in other areas such as forensics, food safety testing, drug discovery & development etc., thereby expanding its potential market size. Similarly, qPCR is being increasingly used in research settings for studying gene expression patterns across different cell types or tissues under different conditions
Scope Of The Report
Report Attributes
Report Details
Report Title
Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Research Report
By Type
dPCR, qPCR
By Application
Clinical, Research Institution, Other
By Companies
Thermo Fisher, Roche, QIAGEN, Bio-rad, Agilent, Bioer, Biosynex, Esco, Analytik Jena, Techne, Fluidigm, RainDance Technologies
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
191
Number of Tables & Figures
134
Customization Available
Yes, the report can be customized as per your need.
Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Report Segments:
The global Digital PCR (dPCR) and Real-Time PCR (qPCR) market is segmented on the basis of:
Types
dPCR, qPCR
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinical, Research Institution, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher
- Roche
- QIAGEN
- Bio-rad
- Agilent
- Bioer
- Biosynex
- Esco
- Analytik Jena
- Techne
- Fluidigm
- RainDance Technologies
Highlights of The Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- dPCR
- qPCR
- By Application:
- Clinical
- Research Institution
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Digital PCR (dPCR) and Real-Time PCR (qPCR) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Digital PCR (dPCR) is a newer technology that uses digital signal processing to improve the accuracy and speed of PCR reactions. qPCR is a more traditional technique that uses real-time detection of gene expression to determine the amount of DNA present in a sample.
Some of the major players in the digital pcr (dpcr) and real-time pcr (qpcr) market are Thermo Fisher, Roche, QIAGEN, Bio-rad, Agilent, Bioer, Biosynex, Esco, Analytik Jena, Techne, Fluidigm, RainDance Technologies.
The digital pcr (dpcr) and real-time pcr (qpcr) market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Digital PCR (dPCR) and Real-Time PCR (qPCR) Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Digital PCR (dPCR) and Real-Time PCR (qPCR) Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size & Forecast, 2020-2028 4.5.1 Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size and Y-o-Y Growth 4.5.2 Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 dPCR
5.2.2 qPCR
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Clinical
6.2.2 Research Institution
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 dPCR
9.6.2 qPCR
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Clinical
9.10.2 Research Institution
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 dPCR
10.6.2 qPCR
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Clinical
10.10.2 Research Institution
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 dPCR
11.6.2 qPCR
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Clinical
11.10.2 Research Institution
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 dPCR
12.6.2 qPCR
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Clinical
12.10.2 Research Institution
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 dPCR
13.6.2 qPCR
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Clinical
13.10.2 Research Institution
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Digital PCR (dPCR) and Real-Time PCR (qPCR) Market: Competitive Dashboard
14.2 Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher
14.3.2 Roche
14.3.3 QIAGEN
14.3.4 Bio-rad
14.3.5 Agilent
14.3.6 Bioer
14.3.7 Biosynex
14.3.8 Esco
14.3.9 Analytik Jena
14.3.10 Techne
14.3.11 Fluidigm
14.3.12 RainDance Technologies